ZA928863B - Crystalline fumaric acid salts of N,N"-disubstituted 9,9-alkylene-3,7-diazbicyclo(3.3.1)nonnane compounds and process for their preparation. - Google Patents

Crystalline fumaric acid salts of N,N"-disubstituted 9,9-alkylene-3,7-diazbicyclo(3.3.1)nonnane compounds and process for their preparation.

Info

Publication number
ZA928863B
ZA928863B ZA928863A ZA928863A ZA928863B ZA 928863 B ZA928863 B ZA 928863B ZA 928863 A ZA928863 A ZA 928863A ZA 928863 A ZA928863 A ZA 928863A ZA 928863 B ZA928863 B ZA 928863B
Authority
ZA
South Africa
Prior art keywords
alkylene
fumaric acid
acid salts
nonnane
diazbicyclo
Prior art date
Application number
ZA928863A
Other languages
English (en)
Inventor
Uwe Schon
Walter Heimann
Uwe Matzel
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Publication of ZA928863B publication Critical patent/ZA928863B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13—Dicarboxylic acids
    • C07C57/15—Fumaric acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA928863A 1991-12-03 1992-11-17 Crystalline fumaric acid salts of N,N"-disubstituted 9,9-alkylene-3,7-diazbicyclo(3.3.1)nonnane compounds and process for their preparation. ZA928863B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4139763A DE4139763A1 (de) 1991-12-03 1991-12-03 Kristalline fumarsaure salze von 9,9-alkylen-3,7-diazabicyclononan-verbindungen und diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
ZA928863B true ZA928863B (en) 1993-05-13

Family

ID=6446125

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA928863A ZA928863B (en) 1991-12-03 1992-11-17 Crystalline fumaric acid salts of N,N"-disubstituted 9,9-alkylene-3,7-diazbicyclo(3.3.1)nonnane compounds and process for their preparation.

Country Status (24)

Country Link
US (1) US5324732A (2)
EP (1) EP0550383B1 (2)
JP (1) JP3180848B2 (2)
KR (1) KR100252389B1 (2)
CN (1) CN1040758C (2)
AT (1) ATE124411T1 (2)
AU (1) AU652869B2 (2)
CA (1) CA2084489C (2)
CZ (1) CZ281930B6 (2)
DE (2) DE4139763A1 (2)
DK (1) DK0550383T3 (2)
DZ (1) DZ1636A1 (2)
ES (1) ES2073900T3 (2)
FI (1) FI100053B (2)
HU (3) HU213672B (2)
IL (1) IL103819A (2)
LT (1) LTIP230A (2)
MX (1) MX9206988A (2)
NO (1) NO300687B1 (2)
NZ (1) NZ245227A (2)
PH (1) PH31114A (2)
SK (1) SK332292A3 (2)
TW (1) TW274084B (2)
ZA (1) ZA928863B (2)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4421324A1 (de) * 1994-06-17 1995-12-21 Kali Chemie Pharma Gmbh Neue 3,7-Diazabicyclo [3,3,1] nonan-Verbindungen enthaltende Arzneimittel
ES2284709T3 (es) * 2000-09-29 2007-11-16 Solvay Pharmaceuticals B.V. Formulacion farmaceutica de liberacion sostenida independiente de la fuerza ionica.
TW200418468A (en) * 2002-11-18 2004-10-01 Solvay Pharm Gmbh Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1]nonane compounds and method of treatments relating to anti-arrhytmic events
AU2004260624A1 (en) * 2003-07-21 2005-02-10 Solvay Pharmaceuticals Gmbh Use of 3,7-diazabicyclo`3, 3,1 !nonane compounds for the treatment and/or prophylaxis of anti-arrhythmic events in male human patients
US20050054667A1 (en) * 2003-07-21 2005-03-10 Solvay Pharmaceuticals Gmbh Method of treating or inhibiting anti-arrhythmic events in male human patients
WO2005030207A1 (en) * 2003-09-26 2005-04-07 Solvay Pharmaceuticals Gmbh Use of 3, 7-diazabicyclo (3.3.1) nonane compounds for the treatment of brugada syndrome

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2551283C3 (de) * 1975-11-14 1981-02-19 Hokuriku Pharmaceutical Co., Ltd., Katsuyama, Fukui (Japan) Monofumarsäuresalz von 3-Pyridylmethylnikotinat und Verfahren zu seiner Herstellung
DE2658558A1 (de) * 1976-12-23 1978-06-29 Bayer Ag Diazabicyclo(3,3,1)nonane, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3234697A1 (de) * 1982-09-18 1984-03-22 Kali-Chemie Pharma Gmbh, 3000 Hannover Neue diazabicyclo-(3,3,1)-nonane
PT88381B (pt) * 1987-09-09 1995-07-06 Kali Chemie Pharma Gmbh Processo para a preparacao de novos compostos 3,7-diazabiciclo{3,3,1} nonano, e de composicoes farmaceuticas que contem estes compostos
US4971992A (en) * 1989-03-27 1990-11-20 Hoechst-Roussel Pharmaceuticals Inc. Carbonate derivatives of eseroline
DE4019080A1 (de) * 1990-06-15 1991-12-19 Kali Chemie Pharma Gmbh Neue 3,7-diazabicycolo (3,3,1)nonan-verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
JPH05247040A (ja) 1993-09-24
DE4139763A1 (de) 1993-06-09
HK1006568A1 (en) 1999-03-05
FI925482A0 (fi) 1992-12-02
KR100252389B1 (ko) 2000-05-01
US5324732A (en) 1994-06-28
PH31114A (en) 1998-02-23
FI925482L (fi) 1993-06-04
NZ245227A (en) 1994-06-27
CZ332292A3 (en) 1993-08-11
NO924647D0 (no) 1992-12-02
CA2084489C (en) 2002-10-08
HU210215A9 (en) 1995-02-28
HU9203698D0 (en) 1993-03-29
IL103819A (en) 1996-09-12
SK279519B6 (sk) 1998-12-02
SK332292A3 (en) 1998-12-02
MX9206988A (es) 1993-06-01
LTIP230A (en) 1994-05-15
AU652869B2 (en) 1994-09-08
CN1040758C (zh) 1998-11-18
CA2084489A1 (en) 1993-06-04
DE59202726D1 (de) 1995-08-03
ES2073900T3 (es) 1995-08-16
CZ281930B6 (cs) 1997-04-16
ATE124411T1 (de) 1995-07-15
CN1072931A (zh) 1993-06-09
HUT63417A (en) 1993-08-30
HU213672B (en) 1997-09-29
KR930012772A (ko) 1993-07-21
IL103819A0 (en) 1993-04-04
EP0550383A1 (de) 1993-07-07
AU2981592A (en) 1993-06-10
NO924647L (no) 1993-06-04
EP0550383B1 (de) 1995-06-28
FI100053B (fi) 1997-09-15
JP3180848B2 (ja) 2001-06-25
DK0550383T3 (da) 1995-08-28
NO300687B1 (no) 1997-07-07
DZ1636A1 (fr) 2002-02-17
TW274084B (2) 1996-04-11

Similar Documents

Publication Publication Date Title
EP0498471A3 (en) Liposomes comprising a guanidino aminoglycoside
AU1610692A (en) Calcium citrate anticaking agent
ZA925128B (en) Pyrrolidine derivatives,their preparation and medicaments containing them
ZM4185A1 (en) Novel compounds
CA2148671A1 (en) Stable Crystalline (6S)-and (6R)-Tetrahydrofolic Acid
GR3006426T3 (2)
GR3017384T3 (en) Process for the preparation of 2,7-Diazabicyclo(3.3.O)octanes.
HUT63417A (en) Process for producing crystalline fumaric acidic salts of 9,9-alkylene-3,7-diazabicyclononane compounds and drugs comprising such compounds
JO1490B1 (en) Innovative vehicles
WO1991013890A3 (fr) Composes diastereoisomeres derivant de l'acide tetrahydrofolique, procede de preparation et utilisation dans la synthese de diastereoisomeres 6s et 6r de folates reduits
EP0331092A3 (en) Alpha-amino-carboxylic-acid derivatives, their preparation and use
HUT45256A (en) Process for producing 1,3,4,9-tetrahydropyrano/3,4-b/indol-1-acetic acid derivatives and pharmaceutical composition containing them
IL94701A0 (en) Crystalline cephem acid addition salts and processes for their preparation
GR3030042T3 (en) Enantiomeric pure cis-2-oxa-5,8-diazabicyclo (4.3.0)nonanes and process for their preparation
ZA883176B (en) Imidazo(1,2-a)-pyrimidines,their salts and process for their preparation
ZA929175B (en) 5,6-dihydro-dibenz(b,e)azepine-6,11-dione-11-oximes.
DE3466877D1 (en) Crystalline salts of l or (s)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters and process
PT82808A (en) Process for the preparation of 1,6-dimethyl-2-halogen-10-alpha-metoxy-ergoline-8beta-methanol 5-bromonicotinate (2-halonicergoline) derivatives and their acid addition salts
EP0601288A3 (en) Substituted 2,3-dicarboxypyridinium nitrates.
ZA857687B (en) Octahydroindolo(2,3-a)quinolizin-1-yl-alkanecarboxylic acid amides and their therapeutically useful acid addition salts,pharmaceutical compositions containing them and process for preparing same
IL70007A (en) 4,6,7,8,9,10-hexahydro-2,3-polymethylene azepino(1,2-a)pyrimidine-4-one derivatives and acid addition salts thereof and pharmaceutical compositions containing them
EP0416602A3 (en) Bis(4-halo-phthalic acid)quarter salts, process for their preparation and their use
CS281088A1 (en) Method of fumaric acid's iron (ii) salts preparation